Stay updated on Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.

Latest updates to the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page
- Check5 days agoChange DetectedThe page shows a new revision number, updating from v3.6.0 to v3.6.3, which reflects an internal update without altering the displayed study details.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedRecruitment status is updated to closed for this study, guiding potential participants appropriately. New help/navigation sections are added, and the Intervention/Treatment heading is reformatted as part of the v3.6.0 update.SummaryDifference0.5%

- Check48 days agoChange DetectedRevision: v3.5.4 was added, replacing v3.5.3. This reflects a new release of the page template or site rather than changes to the study data.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page footer revision label has been updated from v3.5.2 to v3.5.3, reflecting a minor release/version change with no visible impact to the study record details.SummaryDifference0.1%

- Check77 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check106 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.